Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Oral Switch vs IV Antibiotics in Children with Bloodstream Infections
NCT07791914Phase 4Recruiting
- Start
- Sep 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bloodstream infection (BSI) (2 arms). Primary endpoint: Number of Participants with Treatment Failure at 8 weeks. Started Sep 2026; status: recruiting.
02
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT07791914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07791914.